Emerging nosocomial infections and antimicrobial resistance.
Gerberding
J L
JL
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
McGowan
J E
JE
Tenover
F C
FC
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control / Q000635:transmission; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000635:transmission; D013211:Staphylococcus aureus / Q000187:drug effects
D000900:Anti-Bacterial Agents